119th Congress
H.R. 796
Second Chance for Moms Act
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Mary E. Miller(R-IL)
- Introduced
- Jan 28, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce
- Official text
- Introduced in House · Congress.gov page
Cosponsors (13)
Original cosponsors (9)
- Andrew Ogles (R-TN)
- Andrew S. Clyde (R-GA)
- Andy Harris (R-MD)
- Barry Moore (R-AL)
- Brian Babin (R-TX)
- Claudia Tenney (R-NY)
- Daniel Webster (R-FL)
- Randy K. Weber, Sr. (R-TX)
- Riley M. Moore (R-WV)
Added later (4)
- Mark Harris (R-NC) · Feb 4, 2025
- Gary J. Palmer (R-AL) · Feb 6, 2025
- John W. Rose (R-TN) · Feb 26, 2025
- Sheri Biggs (R-SC) · Apr 1, 2025
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
Second Chance for Moms Act of 2025
This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 28, 2025 · House
Referred to the House Committee on Energy and Commerce. - Jan 28, 2025
Introduced in House